HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Osteochondroma

Osteochondroma is a relatively common benign bone tumor characterized by the overgrowth of cartilage and bone near the end of a long bone. It typically manifests during adolescence or early adulthood and is considered a non-cancerous, slow-growing lesion. Osteochondromas are often asymptomatic and may go unnoticed until discovered incidentally during imaging studies for unrelated issues. The exact cause of osteochondroma is not well understood, but it is generally believed to result from a genetic mutation. These tumors most commonly affect the metaphysis of long bones, such as the femur or tibia, and are often found near the growth plates. While the majority of cases involve a solitary lesion, some individuals may develop multiple osteochondromas, a condition known as multiple hereditary exostoses. Clinical evaluation involves physical examination, imaging studies like X-rays, and, in some cases, advanced imaging techniques such as MRI or CT scans. Treatment is usually unnecessary unless the tumor causes pain, impairs joint function, or leads to other complications. Surgical removal may be considered in such cases, with the procedure aimed at eliminating symptoms and preventing potential complications. Prognosis for individuals with osteochondroma is generally favorable. The condition rarely transforms into malignancy, and most people can lead normal, healthy lives with minimal impact on their daily activities. Regular monitoring and medical follow-ups are recommended to ensure early detection of any potential issues and to address them promptly if they arise.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp